Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC

التفاصيل البيبلوغرافية
العنوان: Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC
المؤلفون: Longval, Thomas, Leprêtre, Anne-Claire, Ravinet, Aurélie, Fayard, Amandine, Forcade, Edouard, Coman, Tereza, Redjoul, Rabah, Berceanu, Ana, Buchbinder, Nimrod, Berlie, Guillaume, Mappoura, Maria, Giannotti, Federica, Chevillon, Florian, Robin, Marie, Peffault de Latour, Régis, Sicre de Fontbrune, Flore
المصدر: Bone Marrow Transplantation; 20240101, Issue: Preprints p1-3, 3p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:02683369
14765365
DOI:10.1038/s41409-024-02202-9